ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY
Aim. To evaluate the usefulness of atrial fibrillation (AF) risk predictors for assessment for long-term and short-term risk of its development in patients with metabolic syndrome (MS) during prospective study.Material and methods. During 1998-2008 y. we studied 1968 patients with MS at the age of 4...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2014-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/118 |
| _version_ | 1797857010939592704 |
|---|---|
| author | A. I. Olesin V. A. Litvinenko A. V. Al-Barbari I. V. Konstantinova Z. Yu. Smolin O. N. Prosyanikova |
| author_facet | A. I. Olesin V. A. Litvinenko A. V. Al-Barbari I. V. Konstantinova Z. Yu. Smolin O. N. Prosyanikova |
| author_sort | A. I. Olesin |
| collection | DOAJ |
| description | Aim. To evaluate the usefulness of atrial fibrillation (AF) risk predictors for assessment for long-term and short-term risk of its development in patients with metabolic syndrome (MS) during prospective study.Material and methods. During 1998-2008 y. we studied 1968 patients with MS at the age of 45-75 y. o. All patients underwent common clinical investigation, hemodynamics assessment, late atrial potentials (LAP), P-wave dispersions (Pd), transesophageal electrocardiostimulation with AF risk index (AFRI). After inclusion into the study the patients were followed-up during 1-5 years. The endpoint was absence or presence of AF.Results. In 176 (8,94%) of the patients studied during 4-4,5 year prospective study we marked the onset of paroxysmal and persistent types of AF. If during single assessment of the patients with MS older than 55 y. o. and BMI ≥30 kg/sq.m there is atrial dilatation and/or LAP, pathological values of Pd, and induction of AF with electrocardiostimulation which presuppose long-term risk of AF. Short-term risk (during 1-2 years after the first year postobservational) of AF development in MS can be evaluated only in dynamics: while lowering of AFRI by 20% and more every 3-4 months of observation leads to development of AF during 1-2 years in MS, and in AFRI less than 3 Units with further decline of this parameter by 90% and more during 1-3 months — during 6 months after investigation.Conclusion. Complex investigation of MS patients, that includes assesssment of LAP, Pd, AFRI, improves the evaluation of longand short-term risks of AF development. |
| first_indexed | 2024-04-09T20:49:43Z |
| format | Article |
| id | doaj.art-413ed3a1dd0a4edeb482e462e600a789 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:49:43Z |
| publishDate | 2014-12-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-413ed3a1dd0a4edeb482e462e600a7892023-03-29T21:23:23Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202014-12-01012253010.15829/1560-4071-2014-12-25-30118ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDYA. I. Olesin0V. A. Litvinenko1A. V. Al-Barbari2I. V. Konstantinova3Z. Yu. Smolin4O. N. Prosyanikova5North-Western State Medical University n. a. I. I. Mechnikov, Saint-PetersburgSt. Elisabeth City Hospital, Saint-PetersburgSt. Elisabeth City Hospital, Saint-PetersburgNorth-Western State Medical University n. a. I. I. Mechnikov, Saint-PetersburgSt. Elisabeth City Hospital, Saint-PetersburgSt. Elisabeth City Hospital, Saint-PetersburgAim. To evaluate the usefulness of atrial fibrillation (AF) risk predictors for assessment for long-term and short-term risk of its development in patients with metabolic syndrome (MS) during prospective study.Material and methods. During 1998-2008 y. we studied 1968 patients with MS at the age of 45-75 y. o. All patients underwent common clinical investigation, hemodynamics assessment, late atrial potentials (LAP), P-wave dispersions (Pd), transesophageal electrocardiostimulation with AF risk index (AFRI). After inclusion into the study the patients were followed-up during 1-5 years. The endpoint was absence or presence of AF.Results. In 176 (8,94%) of the patients studied during 4-4,5 year prospective study we marked the onset of paroxysmal and persistent types of AF. If during single assessment of the patients with MS older than 55 y. o. and BMI ≥30 kg/sq.m there is atrial dilatation and/or LAP, pathological values of Pd, and induction of AF with electrocardiostimulation which presuppose long-term risk of AF. Short-term risk (during 1-2 years after the first year postobservational) of AF development in MS can be evaluated only in dynamics: while lowering of AFRI by 20% and more every 3-4 months of observation leads to development of AF during 1-2 years in MS, and in AFRI less than 3 Units with further decline of this parameter by 90% and more during 1-3 months — during 6 months after investigation.Conclusion. Complex investigation of MS patients, that includes assesssment of LAP, Pd, AFRI, improves the evaluation of longand short-term risks of AF development.https://russjcardiol.elpub.ru/jour/article/view/118atrial fibrillationrisk assessment |
| spellingShingle | A. I. Olesin V. A. Litvinenko A. V. Al-Barbari I. V. Konstantinova Z. Yu. Smolin O. N. Prosyanikova ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY Российский кардиологический журнал atrial fibrillation risk assessment |
| title | ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY |
| title_full | ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY |
| title_fullStr | ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY |
| title_full_unstemmed | ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY |
| title_short | ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY |
| title_sort | atrial fibrillation onset risk in patients with metabolic syndrome prospective study |
| topic | atrial fibrillation risk assessment |
| url | https://russjcardiol.elpub.ru/jour/article/view/118 |
| work_keys_str_mv | AT aiolesin atrialfibrillationonsetriskinpatientswithmetabolicsyndromeprospectivestudy AT valitvinenko atrialfibrillationonsetriskinpatientswithmetabolicsyndromeprospectivestudy AT avalbarbari atrialfibrillationonsetriskinpatientswithmetabolicsyndromeprospectivestudy AT ivkonstantinova atrialfibrillationonsetriskinpatientswithmetabolicsyndromeprospectivestudy AT zyusmolin atrialfibrillationonsetriskinpatientswithmetabolicsyndromeprospectivestudy AT onprosyanikova atrialfibrillationonsetriskinpatientswithmetabolicsyndromeprospectivestudy |